Pinta Biotherapeutics Garners $6,311,156 New Financing

  • Feed Type
  • Date
  • Company Name
    Pinta Biotherapeutics
  • Mailing Address
    3260 Bayshore Blvd. Brisbane, CA 94005
  • Company Description
    The company is developing therapies to reverse protein energy wasting in renal disease.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
  • M&A Terms
  • Venture Investor

By posting a comment, you agree to our terms and conditions.